Veradigm Inc. (MDRX)
Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize operations. These include Practice Management software, AI-driven Patient Scheduling tools, and systems for Electronic Statements and Payments. Veradigm also provides comprehensive revenue cycle management, encompassing specialized services and a dedicated clearinghouse to streamline financial workflows. Furthermore, their electronic health records (EHR) portfolio features advanced options like ePrescribe with EPCS, Veradigm HER, and Practice Fusion HER, complemented by a robust Patient Engagement Platform. The firm extends its offerings to network partners through a variety of connectivity solutions. These comprise API integration tools such as Veradigm Connect and Veradigm App Expo, a Diagnostic Ordering and Resulting Network, a Channel Partner Program, and Veradigm ePrescribe Enterprise. Health plans and payers benefit from Veradigm's specialized solutions, which include sophisticated risk adjustment tools like Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics. They also provide quality management systems, including quality analytics and integrated risk adjustment and quality management features. Data exchange and coding solutions, such as eChart Courier, eChart Coder, and eChart Integration and Analytics, further enhance efficiency. Additionally, Veradigm offers provider engagement platforms like Veradigm Payer Insights and the comprehensive Veradigm Payerpath suite. For the biopharma sector, Veradigm supplies valuable real-world data solutions, including extensive health datasets and specialized registries for cardiology and metabolic conditions. This is coupled with real-world evidence platforms, such as the Real World Evidence Analytics Platform. Therapy-focused data is available for key areas like cardiovascular, central nervous system, metabolic, and immunology. The company also delivers Digital Health Media solutions. Established in 1986 and headquartered in Chicago, Illinois, Veradigm Inc. was previously known as Allscripts Healthcare Solutions, Inc., before rebranding to its current name in January 2023.
Sector: Services-Computer Integrated Systems Design
Industry: Medical - Healthcare Information Services
Veradigm Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 108.99M shares outstanding
Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize operations. These include Practice Management software, AI-driven Patient Scheduling tools, and systems for Electronic Statements and Payments. Veradigm also provides comprehensive revenue cycle management, encompassing specialized services and a dedicated clearinghouse to streamline financial workflows. Furthermore, their electronic health records (EHR) portfolio features advanced options like ePrescribe with EPCS, Veradigm HER, and Practice Fusion HER, complemented by a robust Patient Engagement Platform.
The firm extends its offerings to network partners through a variety of connectivity solutions. These comprise API integration tools such as Veradigm Connect and Veradigm App Expo, a Diagnostic Ordering and Resulting Network, a Channel Partner Program, and Veradigm ePrescribe Enterprise. Health plans and payers benefit from Veradigm's specialized solutions, which include sophisticated risk adjustment tools like Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics. They also provide quality management systems, including quality analytics and integrated risk adjustment and quality management features. Data exchange and coding solutions, such as eChart Courier, eChart Coder, and eChart Integration and Analytics, further enhance efficiency.
Additionally, Veradigm offers provider engagement platforms like Veradigm Payer Insights and the comprehensive Veradigm Payerpath suite. For the biopharma sector, Veradigm supplies valuable real-world data solutions, including extensive health datasets and specialized registries for cardiology and metabolic conditions. This is coupled with real-world evidence platforms, such as the Real World Evidence Analytics Platform. Therapy-focused data is available for key areas like cardiovascular, central nervous system, metabolic, and immunology.
The company also delivers Digital Health Media solutions. Established in 1986 and headquartered in Chicago, Illinois, Veradigm Inc. was previously known as Allscripts Healthcare Solutions, Inc., before rebranding to its current name in January 2023.
Leadership
Carol J. Zierhoffer
Director
Dave B. Stevens
Director
Elizabeth A. Altman
Director
Jonathan J. Judge
Director
Employees
2K+
Country
US
Sector
Healthcare
Website
veradigm.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 42.5K | -- | Jun 1, 2026 | |
| Director | Grant/Award | 42.5K | -- | Jun 1, 2026 | |
| Director | Grant/Award | 42.5K | -- | Jun 1, 2026 | |
| Director | Grant/Award | 42.5K | -- | Jun 1, 2026 | |
| Chief Financial Officer | Grant/Award | 318.8K | -- | Jun 1, 2026 | |
| Director | Grant/Award | 42.5K | -- | Jun 1, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Two Seas Capital LP · joint filing· may incl. warrants· filed May 2026 | 8.9M | 8.2% | 13G |
Silver Point Capital, L.P. · joint filing· may incl. warrants· filed May 2026 | 3.6M | 3.3% | 13G |
Trigg Donald Chief Executive Officer, Director | 1.1M | 1.0% | FORM 4 |
Syed Tehsin M CPTO | 645.0K | 0.6% | FORM 4 |
Vakharia Tejal SVP General Counsel | 387.5K | 0.4% | FORM 4 |
Langan Thomas CEO | 327.5K | 0.3% | FORM 4 |
Greyenbuhl Christian Chief Financial Officer | 318.8K | 0.3% | FORM 4 |
Jacobson Eric L SVP Interim General Counsel | 295.3K | 0.3% | FORM 4 |
Bhattacharyya Jay P SVP and General Manager | 278.5K | 0.3% | FORM 4 |
Baker Tally CHRO | 216.5K | 0.2% | FORM 4 |
Insiders
- ASAR VINIT KDirector
- Zierhoffer Carol JDirector
- Rodriguez SusanDirector
- SILVERMAN LOUDirector
- Greyenbuhl ChristianChief Financial Officer
- Stevens David BDirector
- Sacks Jonathan SDirector
- STONEHILL CAPITAL MANAGEMENT LLCDirector
- Felt Bruce C. Jr.Director
- Jacobson Eric LSVP Interim General Counsel
Top institutional holders
based on 108.99M shares outstanding
30d Avg
97.09K
60d Avg
99.79K
90d Avg
83.97K